Home / Recalls / Wells Pharmacy Network LLC / D-0351-2017

D-0351-2017 Class II Terminated

Recalled by Wells Pharmacy Network LLC — Ocala, FL

Recall Details

Product Type: Drugs
Report Date: January 11, 2017
Initiation Date: September 21, 2016
Termination Date: July 2, 2021
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 908 kits (number of vials per kit vary by prescription)

Product Description

Chorionic Gonadotropin Lyophilized, 20,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide

Code Information

All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. Known kit lot code:04212016@42, 06092016@164, 08122016@96. Known vial lot code: 04132016@96, 05242016@1, 08082016@50.

Other recalls by Wells Pharmacy Network LLC

D-0421-2017 Class II — Vitamin D3 in Sesame Oil Injectable 50,000 IU/mL, 5 mL vial, Compounded by Wells (September 21, 2016)
D-0389-2017 Class II — Sermorelin Acetate/GHRP (2) & (6) 9 mg/3.15 mg/3.15 mg Injectable Kit, Compounde (September 21, 2016)
D-0415-2017 Class II — Trimix Injectable 30 mg/1 mg/10 mcg/mL a) 2 mL and b) 5 mL and c) 10 mL vials, C (September 21, 2016)
D-0330-2017 Class II — QUAD3 (PAP/PHEN/ALPRO/ATRO) 30 mg/3 mg/30 mcg/0.1mL Injectable, a) 2 mL and 5 mL (September 21, 2016)
D-0350-2017 Class II — Chorionic Gonadotropin, Lyophilized, 7,500 unit Injectable Kit, Compounded by We (September 21, 2016)
D-0332-2017 Class II — MIC Combo - Standard 15 mg/50 mg/100 mg/mL Injectable, 30 mL vials, Compounded b (September 21, 2016)
D-0327-2017 Class II — Testosterone Cypionate in Grapeseed Oil Injectable, 200 mg/mL, a) 1 mL b) 3 mL c (September 21, 2016)
D-0371-2017 Class II — MIC/BCOMP+CAR+ARG+CHR+LID 12.5 mg/25 mg/25 mg/25 mg/12.5 mg/0.2 mg/20 mg/mL Inje (September 21, 2016)
D-0408-2017 Class II — Tri 2 (PAP/PHEN/ATROPINE) NR Injectable, 30 mg/3 mg/0.3 mg/mL, a) 2 mL and b) 5 (September 21, 2016)
D-0368-2017 Class II — MIC/B12(M) 15 mg/50 mg/100 mg/1 mg/mL Injectable, 30 mL vial, Compounded by Well (September 21, 2016)